Login Get Started
Browse
Shares
Healthcare
Biotechnology & Medical Research
Cellect Biotechnology
Cellect Biotechnology logo

APOP - Cellect Biotechnology Share News

$3.17 0.0  0.3%

Last Trade - 22/01/21

Sector
Healthcare
RiskRating
Speculative
Size
Micro Cap
Style
Sucker Stock
Market Cap £5.28m
Enterprise Value £805k
Revenue £n/a
Position in Universe 6152nd / 6630
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions APOP Dividends
All News
All News Reuters News Company Announcements
BRIEF-Cellect Biotechnology Granted Key European Patent For Its Stem Cell Selection Technology
7th Aug '18 News
BRIEF-Cellect Signs Strategic Agreement With Swiss Biotech Center
9th Jul '18 News
BRIEF-Cellect Biotechnology Q1 Loss Per Ads $0.16
17th May '18 News
BRIEF-Cellect Biotechnology Successfully Completed Proof Of Concept Testing For First Scalable Production Of Apotainer
9th Apr '18 News
BRIEF-Cellect Biotechnology Q4 Loss Per Share ‍$0.008​
19th Mar '18 News
BRIEF-Cellect Biotechnology Announces $4 Mln Registered Direct Offering
29th Jan '18 News
BRIEF-Cellect Announces Opening Of Second Clinical Trial Site And Approval From Safety Board (DSMB) For Dose Escalation
16th Jan '18 News
BRIEF-Cellect Biotechnology Announces Clinical Results
4th Jan '18 News
BRIEF-Cellect Biotechnology Ltd Files Prospectus Related To Resale Of Shares
28th Dec '17 News
BRIEF-Cellect Biotechnology reports Q3 loss $0.02/shr
22nd Nov '17 News
BRIEF-Cellect appoints Ronit Bakimer-Kleiner as chief development officer
19th Oct '17 News
BRIEF-Cellect Biotechnology announces $4.3 million raise in a registered direct offering
7th Sep '17 News
BRIEF-Cellect Biotechnology files for mixed shelf of upto $75 mln
1st Aug '17 News
© Stockopedia 2021, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.